0001209191-23-003987.txt : 20230119
0001209191-23-003987.hdr.sgml : 20230119
20230119160142
ACCESSION NUMBER: 0001209191-23-003987
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230117
FILED AS OF DATE: 20230119
DATE AS OF CHANGE: 20230119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Levisetti Matteo
CENTRAL INDEX KEY: 0001962444
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 23537436
MAIL ADDRESS:
STREET 1: C/O CUE BIOPHARMA, INC.
STREET 2: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-01-17
0
0001645460
Cue Biopharma, Inc.
CUE
0001962444
Levisetti Matteo
C/O CUE BIOPHARMA, INC.
40 GUEST STREET
BOSTON
MA
02135
0
1
0
0
Chief Medical Officer
Common Stock
9230
D
Stock Option (right to buy)
13.14
2031-02-21
Common Stock
75000
D
Stock Option (right to buy)
6.91
2032-02-08
Common Stock
43000
D
Stock Option (right to buy)
5.01
2032-03-24
Common Stock
10000
D
These stock options become exercisable in eight equal semi-annual installments beginning August 22, 2021.
These stock options become exercisable in eight equal semi-annual installments beginning August 9, 2022.
These stock options become exercisable in eight equal semi-annual installments beginning September 25, 2022.
/s/ Matteo Levisetti by Colin Sandercock, attorney-in-fact
2023-01-19